MedPath

ext generation optical coherence tomography for improved detection of early Barrett*s neoplasia

Completed
Conditions
Barrett's esophagus
early esophageal cancer
10017990
Registration Number
NL-OMON47641
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

- Age > 18 years;
- Known BE, defined as columnar lined epithelium of the esophagus containing intestinal metaplasia upon biopsy, with or without dysplasia (low-grade or high-grade dysplasia or early adenocarcinoma);
- Signed informed consent.

Exclusion Criteria

- Presence of an esophageal mass that precludes full distention of the balloon from the NvisionVLE Optical Probe;
- Patients with esophageal strictures that would prevent adequate expansion of the balloon from the NvisionVLE Optical Probe;
- Patients with known inflammatory disease, esophageal tears or ulcers, which would prohibit full distention of the balloon from the NvisionVLE Optical Probe;
- Contraindications for ER and/or obtain biopsies (e.g. due to anticoagulation, coagulation disorders, esophageal varices);
- Previously treated dysplasia by either ER and/or ablation therapy;
- Unable to provide signed informed consent.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Per area and per patient analysis of diagnostic accuracy of both the VLE<br /><br>prediction score and the VLE computer algorithm.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Inter-observer agreement of the VLE prediction score<br /><br>- Identification of additional in-vivo clinical features predictive of early<br /><br>neoplasia<br /><br>- Time to analyse a complete VLE scan using the VLE prediction score;<br /><br>- Time to analyse a complete VLE scan using the computer algorithm.</p><br>
© Copyright 2025. All Rights Reserved by MedPath